ESC Premium Access

Which antithrombotic therapy after percutaneous coronary intervention (PCI)?

Presentation

About the speaker

Professor Kyung Woo Park

Seoul (Korea (Republic of))
4 presentations
0 follower

3 more presentations in this session

Aspirin in primary prevention: is it still valid?

Speaker: Professor J. Armitage (Oxford, GB)

Thumbnail

Which antithrombotic therapy after transcatheter aortic valve procedure (TAVI)?

Speaker: Professor S. Windecker (Bern, CH)

Thumbnail

Current controversies in antithrombotic therapy - panel discussion.

Thumbnail

Access the full session

Current controversies in antithrombotic therapy

Speakers: Professor K. Park, Professor J. Armitage, Professor S. Windecker
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2021

2 December - 4 December 2021

Sessions Presentations

This platform is supported by

logo Novo Nordisk